LSTM Home > LSTM Research > LSTM Online Archive

Determining the value of TB active case-finding: current evidence and methodological considerations

Sohn, H., Sweeney, S., Mudzengi, D., Creswell, J., Menzies, N. A., Fox, G. J., MacPherson, Peter ORCID: https://orcid.org/0000-0002-0329-9613 and Dowdy, D. W. (2021) 'Determining the value of TB active case-finding: current evidence and methodological considerations'. The International Journal of Tuberculosis and Lung Disease, Vol 25, Issue 3, pp. 171-181.

[img] Text
IJTLD_SOA_ACFCEA_final_R1_final1.docx - Accepted Version
Restricted to Repository staff only until 1 September 2021.

Download (399kB)

Abstract

Active case-finding (ACF) is an important component of the End TB Strategy. However, ACF is resource-intensive, and the economics of ACF are not well-understood. Data on the costs of ACF are limited, with little consistency in the units and methods used to estimate and report costs. Mathematical models to forecast the long-term effects of ACF require empirical measurements of the yield, timing and costs of case detection. Pragmatic trials offer an opportunity to assess the cost-effectiveness of ACF interventions within a 'real-world´ context. However, such analyses generally require early introduction of economic evaluations to enable prospective data collection on resource requirements. Closing the global case-detection gap will require substantial additional resources, including continued investment in innovative technologies. Research is essential to the optimal implementation, cost-effectiveness, and affordability of ACF in high-burden settings. To assess the value of ACF, we must prioritize the collection of high-quality data regarding costs and effectiveness, and link those data to analytical models that are adapted to local settings.

Item Type: Article
Subjects: W General Medicine. Health Professions > W 74 Medical economics. Health care costs
WA Public Health > Health Administration and Organization > WA 590 Health education, Health communication
WC Communicable Diseases > WC 20 Research (General)
WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General)
Faculty: Department: Clinical Sciences & International Health > Malawi-Liverpool-Wellcome Programme (MLW)
Digital Object Identifer (DOI): https://doi.org/10.5588/ijtld.20.0565
Depositing User: Stacy Murtagh
Date Deposited: 11 Mar 2021 11:57
Last Modified: 16 Apr 2021 12:46
URI: https://archive.lstmed.ac.uk/id/eprint/17238

Statistics

View details

Actions (login required)

Edit Item Edit Item